147 related articles for article (PubMed ID: 23702580)
1. Genetic variation of platelet function and pharmacology: an update of current knowledge.
Geisler T; Schaeffeler E; Gawaz M; Schwab M
Thromb Haemost; 2013 Nov; 110(5):876-87. PubMed ID: 23702580
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
3. Common variations in platelet glycoproteins: pharmacogenomic implications.
Quinn MJ; Topol EJ
Pharmacogenomics; 2001 Nov; 2(4):341-52. PubMed ID: 11722284
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants that affect platelet function.
Kunicki TJ; Williams SA; Nugent DJ
Curr Opin Hematol; 2012 Sep; 19(5):371-9. PubMed ID: 22872156
[TBL] [Abstract][Full Text] [Related]
5. Variability of platelet indices and function: acquired and genetic factors.
de Gaetano G; Santimone I; Gianfagna F; Iacoviello L; Cerletti C
Handb Exp Pharmacol; 2012; (210):395-434. PubMed ID: 22918740
[TBL] [Abstract][Full Text] [Related]
6. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
Tantry US; Bonello L; Aradi D; Price MJ; Jeong YH; Angiolillo DJ; Stone GW; Curzen N; Geisler T; Ten Berg J; Kirtane A; Siller-Matula J; Mahla E; Becker RC; Bhatt DL; Waksman R; Rao SV; Alexopoulos D; Marcucci R; Reny JL; Trenk D; Sibbing D; Gurbel PA;
J Am Coll Cardiol; 2013 Dec; 62(24):2261-73. PubMed ID: 24076493
[TBL] [Abstract][Full Text] [Related]
7. The platelet--thrombosis and beyond.
Langer HF; Weber C; Gawaz M
Thromb Haemost; 2013 Nov; 110(5):857-8. PubMed ID: 24108387
[No Abstract] [Full Text] [Related]
8. The P2Y12 receptor as a therapeutic target in cardiovascular disease.
Storey RF
Platelets; 2001 Jun; 12(4):197-209. PubMed ID: 11454254
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel response variability and the advent of personalised antiplatelet therapy. A bench to bedside journey.
Gurbel PA; Tantry US
Thromb Haemost; 2011 Aug; 106(2):265-71. PubMed ID: 21713326
[TBL] [Abstract][Full Text] [Related]
10. The genetics of aspirin resistance.
Goodman T; Sharma P; Ferro A
Int J Clin Pract; 2007 May; 61(5):826-34. PubMed ID: 17391325
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients.
Gurbel PA; DiChiara J; Tantry US
Am J Cardiol; 2007 Oct; 100(8B):18M-25M. PubMed ID: 17950828
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study pinpoints a new functional apolipoprotein B variant influencing oxidized low-density lipoprotein levels but not cardiovascular events: AtheroRemo Consortium.
Mäkelä KM; Seppälä I; Hernesniemi JA; Lyytikäinen LP; Oksala N; Kleber ME; Scharnagl H; Grammer TB; Baumert J; Thorand B; Jula A; Hutri-Kähönen N; Juonala M; Laitinen T; Laaksonen R; Karhunen PJ; Nikus KC; Nieminen T; Laurikka J; Kuukasjärvi P; Tarkka M; Viik J; Klopp N; Illig T; Kettunen J; Ahotupa M; Viikari JS; Kähönen M; Raitakari OT; Karakas M; Koenig W; Boehm BO; Winkelmann BR; März W; Lehtimäki T
Circ Cardiovasc Genet; 2013 Feb; 6(1):73-81. PubMed ID: 23247145
[TBL] [Abstract][Full Text] [Related]
13. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease.
Wang TY; Angiolillo DJ; Cushman M; Sabatine MS; Bray PF; Smyth SS; Dauerman HL; French PA; Becker RC
J Am Coll Cardiol; 2012 Mar; 59(10):891-900. PubMed ID: 22381424
[TBL] [Abstract][Full Text] [Related]
14. The genetics of antiplatelet drug resistance.
Feher G; Feher A; Pusch G; Lupkovics G; Szapary L; Papp E
Clin Genet; 2009 Jan; 75(1):1-18. PubMed ID: 19067731
[TBL] [Abstract][Full Text] [Related]
15. What we have learned from inherited platelet disorders.
Israels SJ; Rand ML
Pediatr Blood Cancer; 2013; 60 Suppl 1():S2-7. PubMed ID: 23109117
[TBL] [Abstract][Full Text] [Related]
16. Scientific and therapeutic advances in antiplatelet therapy.
Bhatt DL; Topol EJ
Nat Rev Drug Discov; 2003 Jan; 2(1):15-28. PubMed ID: 12509756
[TBL] [Abstract][Full Text] [Related]
17. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.
Siller-Matula J; Schrör K; Wojta J; Huber K
Thromb Haemost; 2007 Mar; 97(3):385-93. PubMed ID: 17334505
[TBL] [Abstract][Full Text] [Related]
18. New anti-platelet agents: the end of resistance?
Kastrati A
Thromb Res; 2012 Oct; 130 Suppl 1():S53-5. PubMed ID: 23026663
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet agents: current drugs and future trends.
Messmore HL; Jeske WP; Wehrmacher W; Coyne E; Mobarhan S; Cho L; Leya FS; Moran JF
Hematol Oncol Clin North Am; 2005 Feb; 19(1):87-117, vi. PubMed ID: 15639110
[TBL] [Abstract][Full Text] [Related]
20. Advances in the monitoring of anti-P2Y12 therapy.
Harrison P
Platelets; 2012; 23(7):510-25. PubMed ID: 22916724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
